Online abortion drug sales in Indonesia: a quality of care assessment
Loading...
Authors
Moore, Ann M.
Philbin, Jesse
Ariawan, Iwan
Budiharsana, Meiwita
Murro, Rachel
Aryanty, Riznawaty Imma
Bankole, Akinrinola
Issue Date
2020-10-20
Type
Article
Language
en_US
Keywords
Online , Abortion Drug Sales , Indonesia , Quality of Care , Assessment
Alternative Title
Abstract
This study sought to understand the experience of buying misoprostol online for pregnancy termination in Indonesia. We conducted a mystery client study August through October, 2019. Interactions were analyzed quantitatively and qualitatively, along with the contents of the packages. One hundred ten sellers were contacted, from whom mystery clients made 76 purchases and received 64 drug packages. Almost all sellers sold “packets” containing multiple drugs; 73 percent of packets contained misoprostol, and 47 percent contained at least 800 mcg of misoprostol. Thirty-four packets contained insufficient drugs to complete an abortion. When compared to WHO standards, 87 percent of sellers imparted incomplete information about potential physical effects; no seller provided information about possible complications. Women buying misoprostol from informal online drugs sellers will be underprepared for understanding potential side effects and complications. Educational activities are needed to increase women's access to information about safe use of misoprostol as a harm reduction strategy.
Description
Citation
Moore, A. M., Philbin, J., Ariawan, I., Budiharsana, M., Murro, R., Aryanty, R. I., & Bankole, A. (2020). Online Abortion Drug Sales in Indonesia: A Quality of Care Assessment. Studies in Family Planning, 51(4), 295–308. https://doi.org/10.1111/sifp.12138
Publisher
Studies in Family Planning